When should I get a coronary calcium score?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Get a Coronary Artery Calcium Score

Coronary artery calcium (CAC) scoring should be obtained in asymptomatic adults aged 40-75 years with intermediate cardiovascular risk (7.5%-20% 10-year ASCVD risk) when the decision about statin therapy remains uncertain after initial risk assessment. 1

Primary Indications for CAC Scoring

Intermediate-Risk Patients (The Sweet Spot)

  • CAC scoring is most valuable for asymptomatic adults with 10-20% 10-year ASCVD risk where treatment decisions are genuinely uncertain 1
  • This represents the population where CAC can reclassify more than half of patients and fundamentally alter management decisions 2
  • Age ≥40 years is the minimum threshold across all major guidelines 1

Borderline-Risk Patients (Selected Cases)

  • Consider CAC in adults with 5-7.5% 10-year ASCVD risk who have risk-enhancing factors 1
  • Risk-enhancing factors include:
    • Family history of premature ASCVD 1
    • Persistently elevated LDL-C ≥160 mg/dL or triglycerides ≥175 mg/dL 1
    • Chronic kidney disease 1
    • Metabolic syndrome 1
    • South Asian ethnicity 1
    • Elevated lipoprotein(a) >50 mg/dL or hs-CRP ≥2.0 mg/L 1
    • Conditions specific to women (preeclampsia, premature menopause) 1
    • Inflammatory diseases (rheumatoid arthritis, psoriasis, HIV) 1

Low-Risk Patients (Very Limited Use)

  • Generally NOT indicated for patients with <5% 10-year ASCVD risk 3, 2
  • Exception: May be reasonable in low-risk patients with strong family history of premature CAD, but only if this would genuinely change management decisions 1
  • A 41-year-old woman with 0.4% 10-year risk and family history alone does NOT meet criteria for CAC scoring 3

Special Populations

Diabetes Mellitus:

  • Consider CAC in younger diabetic patients (Type 1 DM <35 years, Type 2 DM <50 years) with diabetes duration <10 years and no other risk factors 1
  • Reasonable for diabetic patients aged 40-60 years when treatment decisions are uncertain 1

High-Risk Patients Reluctant to Accept Treatment:

  • CAC may be indicated when high-risk patients refuse recommended statin therapy, as a CAC >100 may motivate adherence 1

When NOT to Get CAC Scoring

Absolute Contraindications

  • Patients with known clinical ASCVD (prior MI, stroke, revascularization) - they already need maximal therapy 1
  • Very low-risk patients (<5% 10-year risk) without risk-enhancing factors - radiation exposure cannot be justified 3
  • Very high-risk patients (>20% 10-year risk) - they already need aggressive treatment regardless of CAC 4
  • Patients already on optimal medical therapy where results would not change management 2

Relative Contraindications

  • Age <40 years for most patients (very low prevalence of detectable calcium) 3
  • Patients unwilling to consider statin therapy regardless of results 4
  • When the result would not influence clinical decision-making 4

How CAC Results Guide Management

CAC = 0 (Very Low Risk)

  • Downgrade risk and withhold statin therapy in most cases 1
  • 10-year event rate only 1.5-3.0% 1
  • Important exceptions where statins may still be considered despite CAC = 0: 1
    • Active smoking
    • Diabetes mellitus
    • Family history of premature CHD
  • Repeat CAC in 3-7 years if risk factors persist 1

CAC = 1-99 (Mild Elevation)

  • Favors statin therapy, especially for patients aged >55 years 1
  • Modest risk reclassification upward 1
  • In intermediate-risk patients with CAC 1-99, observed event rate is 6.5-10.4% 1
  • Consider repeating CAC in 3-5 years if treatment deferred 1

CAC ≥100 or ≥75th Percentile (High Risk)

  • Initiate moderate-to-high intensity statin therapy 1
  • Event rate ≥20 per 1000 person-years, approximating secondary prevention population 1
  • Number needed to treat with statin = 30 to prevent one ASCVD event over 5 years 2

CAC ≥300-400 (Very High Risk)

  • High-intensity statin therapy strongly recommended 1
  • Consider aspirin 81 mg daily per some specialty guidelines 1

CAC ≥1000 (Extremely High Risk)

  • Should be considered a distinct patient group requiring aggressive risk factor modification 5
  • High-intensity statin therapy mandatory 1

Common Pitfalls to Avoid

Pitfall #1: Ordering CAC in truly low-risk patients

  • A patient with <5% 10-year risk and no risk-enhancing factors should NOT get CAC 3
  • The radiation exposure (approximately 1.5 mSv) cannot be justified 3

Pitfall #2: Ignoring CAC >0 in "low-risk" patients

  • Any detectable calcium (CAC >0) indicates definite atherosclerosis and should not be dismissed, even if traditional risk calculators suggest low risk 2
  • CAC represents only ~20% of total atherosclerosis burden 2

Pitfall #3: Ordering CAC when results won't change management

  • Always counsel patients BEFORE testing that results may lead to statin therapy 4
  • If patient refuses statins regardless of results, don't order the test 4

Pitfall #4: Repeating CAC too soon

  • Minimum interval between scans should be 3-5 years 1, 2
  • Serial CAC has limited utility in patients already on optimal medical therapy 2

Pitfall #5: Confusing CAC with degree of stenosis

  • CAC indicates atherosclerosis burden but does NOT correlate with degree of luminal narrowing 2
  • Asymptomatic patients with elevated CAC do not routinely need stress testing or angiography 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Coronary Artery Calcium Score

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Denial of Coronary Artery Calcium Scoring in Low-Risk Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.